UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019675
Receipt number R000022736
Scientific Title Effectiveness of referral system for the management of heart failure with tolvaptan
Date of disclosure of the study information 2015/11/09
Last modified on 2021/11/11 15:43:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effectiveness of referral system for the management of heart failure with tolvaptan

Acronym

Referral system for heart failure with tolvaptan

Scientific Title

Effectiveness of referral system for the management of heart failure with tolvaptan

Scientific Title:Acronym

Referral system for heart failure with tolvaptan

Region

Japan


Condition

Condition

congestive heart failure

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and safety of the referral system for the management of diuretics-resistant congestive heart failure with tolvaptan

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Scale of signs, symptoms, and parameters of congestion at 6 months after the administration of tolvaptan

Key secondary outcomes

all-cause mortality, cardiovascular mortality, re-admission for heart failure, and chenges in kidney function


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Other

Interventions/Control_1

Referral for the initiation of tolvaptan from clinic to hospital

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with congestive heart failure, refractory to the treatment with conventional diuretics

Key exclusion criteria

1. Petients with history of the adverse effects of tolvaptan
2. Patients on dialysis
3. Pregnant women, women who may be pregnant, and breast-feeding women
4. Patients with serum sodium over 145 mEq/L
5. Patients who cannot take medicine orally

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Masato
Middle name
Last name Watarai

Organization

Anjo Kosei Hospital

Division name

Cardiovascular Center

Zip code

446-8602

Address

28, Higashi-hirokute, Anjo-cho, Anjo City, Aichi

TEL

0566-75-2111

Email

junnai@kosei.anjo.aichi.jp


Public contact

Name of contact person

1st name Uemura
Middle name
Last name Yusuke

Organization

Anjo Kosei Hospital

Division name

Cardiovascular Center

Zip code

446-8602

Address

28, Higashi-hirokute, Anjo-cho, Anjo City, Aichi

TEL

0566-75-2111

Homepage URL


Email

yusuke0307@hotmail.com


Sponsor or person

Institute

Cardiovascular Center, Anjo Kosei Hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Anjo Kosei Hospital

Address

28, Higashi-Hirokute, Anjo-cho, Anjo, JAPAN

Tel

0566-75-2111

Email

junnai@kosei.anjo.aichi.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 11 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 09 Month 15 Day

Date of IRB

2015 Year 09 Month 15 Day

Anticipated trial start date

2015 Year 09 Month 15 Day

Last follow-up date

2020 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 11 Month 07 Day

Last modified on

2021 Year 11 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022736


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name